Impel NeuroPharma Inc. Company Profile

06:10 EST 11th December 2018 | BioPortfolio

Impel NeuroPharma Inc. is a biopharmaceutical company specializing in developing enhanced CNS products based on its proprietary Precision Olfactory Delivery (POD) technology.

News Articles [16 Associated News Articles listed on BioPortfolio]

Impel NeuroPharma starts THOR 201 trial for Parkinson’s disease

US-based biotechnology company Impel NeuroPharma has commenced the Therapeutic Benefit of Intranasal Levodopa in Parkinson’s Disease OFF Reversal (THOR 201)...Read More... The post Impel NeuroPharma...

Biotech startup Impel NeuroPharma raises $67.5M

Impel NeuroPharma, a startup working on ways to deliver medications to the brain more efficiently than current methods, raise -More- 

Impel NeuroPharma doses first patient in Phase lll trial of INP104

Impel NeuroPharma has dosed the first patient in the Phase lll Safety and Tolerability of POD-DHE (STOP-301) trial to investigate...Read More... The post Impel NeuroPharma doses first patient in Phase...

Allergan’s Ellen Lubman Joins Impel NeuroPharma’s C-Suite

Impel NeuroPharma has appointed Ellen Lubman to serve as its chief business officer. Lubman comes to the Seattle biotech from Allergan (NYSE: AGN), where she was vice president of external science and...

Impel NeuroPharma Closes $67.5 Million Series D to Advance CNS Portfolio

Seattle-based Impel NeuroPharma closed on a Series D financing totaling $67.5 million. It was co-led by KKR and Northwest Venture Partners. Existing investors Vivo Capital, 5AM Ventures and venBio Par...

Impel Raises $67.5M to Advance Intranasal Drugs for CNS Disorders

Impel NeuroPharma, which is developing technology to deliver certain therapeutics more effectively to the brain, says it has raised $67.5 million in new funding to support clinical trials of its drug ...

Impel doses first subject in Phase l trial of INP105

Impel NeuroPharma has dosed the first subject in the Phase l Safety and Tolerability of Intranasal POD-olanzapine (SNAP 101) trial...Read More... The post Impel doses first subject in Phase l trial of...

Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Tr...

Impel expects to commence enrollment in the pivotal Phase 3 study evaluating the safety and tolerability of long-term, intermittent use of INP104 for the treatment of acute migraine headache in H2 201...

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Preemptive Dengue Control Strategy in Pakistan.

Dengue has proven to be a serious health threat all around the world. It is the most rapidly spreading vector-borne disease that affects approximately 50 million people annually. Pakistan, being a thi...

Utilization of waste medicine wrappers as an efficient low-cost electrode material for microbial fuel cell.

Waste generation from healthcare facilities now has become a concerning issue as it contains plastic and metals. Medicine wrappers are one of the major portion of healthcare solid waste, which impel i...

Clinical Trials [0 Results]


Companies [4 Associated Companies listed on BioPortfolio]

Impel NeuroPharma, Inc.

Impel NeuroPharma, Inc. is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel NeuroPharma has developed a novel drug d...

Impel NeuroPharma Inc.

Impel NeuroPharma Inc. is a biopharmaceutical company specializing in developing enhanced CNS products based on its proprietary Precision Olfactory Delivery (POD) technology.

Impel NeuroPharma

Based in Seattle, WA, Impel NeuroPharma is a medical device company whose Pressurized Olfactory Delivery technology enables pharmaceutical drugs to bypass the blood-brain barrier ...

Maas Biolab, Inc.

Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzhe...

More Information about "Impel NeuroPharma Inc." on BioPortfolio

We have published hundreds of Impel NeuroPharma Inc. news stories on BioPortfolio along with dozens of Impel NeuroPharma Inc. Clinical Trials and PubMed Articles about Impel NeuroPharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Impel NeuroPharma Inc. Companies in our database. You can also find out about relevant Impel NeuroPharma Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Corporate Database Quicklinks

Searches Linking to this Company Record